660 related articles for article (PubMed ID: 17215092)
21. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
Fachinger V; Bischoff R; Jedidia SB; Saalmüller A; Elbers K
Vaccine; 2008 Mar; 26(11):1488-99. PubMed ID: 18304705
[TBL] [Abstract][Full Text] [Related]
22. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.
Meerts P; Misinzo G; Lefebvre D; Nielsen J; Bøtner A; Kristensen CS; Nauwynck HJ
BMC Vet Res; 2006 Jan; 2():6. PubMed ID: 16445856
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination.
Aravindaram K; Kuo TY; Lan CW; Yu HH; Wang PH; Chen YS; Chen GH; Yang NS
J Gene Med; 2009 Apr; 11(4):288-301. PubMed ID: 19194994
[TBL] [Abstract][Full Text] [Related]
25. Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study.
Wellenberg GJ; Stockhofe-Zurwieden N; de Jong MF; Boersma WJ; Elbers AR
Vet Microbiol; 2004 Apr; 99(3-4):203-14. PubMed ID: 15066723
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes.
Gamage LN; Ellis J; Hayes S
Vaccine; 2009 Nov; 27(47):6595-604. PubMed ID: 19712770
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs.
Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D
Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636
[TBL] [Abstract][Full Text] [Related]
28. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
[TBL] [Abstract][Full Text] [Related]
29. Immunisation against PCV2 structural protein by DNA vaccination of mice.
Kamstrup S; Barfoed AM; Frimann TH; Ladekjaer-Mikkelsen AS; Bøtner A
Vaccine; 2004 Mar; 22(11-12):1358-61. PubMed ID: 15063557
[TBL] [Abstract][Full Text] [Related]
30. Immune responses and vaccine-induced immunity against Porcine circovirus type 2.
Kekarainen T; McCullough K; Fort M; Fossum C; Segalés J; Allan GM
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):185-93. PubMed ID: 20451259
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
32. Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line.
Zhu Y; Lau A; Lau J; Jia Q; Karuppannan AK; Kwang J
Virology; 2007 Dec; 369(2):423-30. PubMed ID: 17889922
[TBL] [Abstract][Full Text] [Related]
33. [Construction and immunogenicity of recombinant adenoviruses expressing Cap protein of PCV2 and GP5 protein of PRRSV in mice].
Wang X; Li Y; Jiang P
Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1639-45. PubMed ID: 20222461
[TBL] [Abstract][Full Text] [Related]
34. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
35. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
[TBL] [Abstract][Full Text] [Related]
36. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark.
Grau-Roma L; Hjulsager CK; Sibila M; Kristensen CS; López-Soria S; Enøe C; Casal J; Bøtner A; Nofrarías M; Bille-Hansen V; Fraile L; Baekbo P; Segalés J; Larsen LE
Vet Microbiol; 2009 Mar; 135(3-4):272-82. PubMed ID: 19027247
[TBL] [Abstract][Full Text] [Related]
37. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.
Lin HX; Ma Z; Fan HJ; Lu CP
Vaccine; 2012 Sep; 30(44):6307-13. PubMed ID: 22884664
[TBL] [Abstract][Full Text] [Related]
38. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
39. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
40. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.
Fort M; Sibila M; Allepuz A; Mateu E; Roerink F; Segalés J
Vaccine; 2008 Feb; 26(8):1063-71. PubMed ID: 18237827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
